Definitions of exacerbations: does it really matter in clinical trials on COPD?

T.W. Effing; H.A.M. Kerstjens; E.M. Monninkhof; P. van der Valk; E.F. Wouters; D.S. Postma; G.A. Zielhuis; J. van der Palen

doi:10.1378/chest.08-1680

Definitions of exacerbations: does it really matter in clinical trials on COPD?

Translated title of the contribution: Definitions of exacerbations: does it really matter in clinical trials on COPD?

T.W. Effing
, H.A.M. Kerstjens
, E.M. Monninkhof
, P. van der Valk
, E.F. Wouters
, D.S. Postma
, G.A. Zielhuis
, J. van der Palen

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Definitions of exacerbations: does it really matter in clinical trials on COPD?
Original language	Undefined/Unknown
Pages (from-to)	918-923
Number of pages	6
Journal	Chest
Volume	136
Issue number	3
DOIs	https://doi.org/10.1378/chest.08-1680
Publication status	Published - 2009

Access to Document

10.1378/chest.08-1680

Cite this

@article{3a18b6ff1b114876a0d6a42ffa64fdbc,

title = "Definitions of exacerbations: does it really matter in clinical trials on COPD?",

author = "T.W. Effing and H.A.M. Kerstjens and E.M. Monninkhof and \{van der Valk\}, P. and E.F. Wouters and D.S. Postma and G.A. Zielhuis and \{van der Palen\}, J.",

year = "2009",

doi = "10.1378/chest.08-1680",

language = "Undefined/Unknown",

volume = "136",

pages = "918--923",

journal = "Chest",

issn = "0012-3692",